---
$id: https://graph.org.ai/products/commodity/51161521
$type: Product
source: UNSPSC
code: "51161521"
title: "Cilomilast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cilomilast

**UNSPSC Code**: 51161521
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C20H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ATB1C1R6X, chemically known as cyclohexanecarboxylic acid, 4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)-, cis- but generally known as cilomilast, which bears US NIH Compound Identifier 151170. European Medicines Agency schedules Cilomilast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01296MIG. The term CILOMILAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule cilomilast under HS 29269095 and SITC 51484. As of Q4 2014, CILOMILAST remains the US FDA Preferred Term for this commodity. Cilomilast bears US NLM identifiers UMLS ID C0968887 and NCI Concept Code C95232. SMILES: O(C1CCCC1)C1CC(C2(CCC(CC2)C(=O)O)C#N)CCC1OC.

